|
Real-time Estimate
Cboe BZX
11:42:04 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 9.445 USD | +1.12% |
|
-1.41% | -48.38% |
| 08-05 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
| Market Cap | 2.09B 1.8B 1.69B 1.54B 2.91B 200B 2.92B 20.05B 7.82B 101B 7.85B 7.68B 335B | P/E 2026 * |
11.5x | P/E 2027 * | 9.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 1.8B 1.69B 1.54B 2.91B 200B 2.92B 20.05B 7.82B 101B 7.85B 7.68B 335B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 2.99x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : ADMA Biologics, Inc.
| 22-12-07 | Wall Street lager gesloten | |
| 22-12-07 | Wall Street koerst af op vlak slot | |
| 22-12-07 | Wall Street verder omlaag bij opening | |
| 22-12-07 | Futures Wall Street wijzen omlaag | |
| 17-03-30 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | +1.12% | ||
| 1 week | -1.41% | ||
| Current month | +11.29% | ||
| 1 month | +11.29% | ||
| 3 months | +19.18% | ||
| 6 months | -42.52% | ||
| Current year | -48.38% |
| 1 week | 9.22 |  | 9.76 |
| 1 month | 8.57 | | 10.35 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.06 | | 25.67 |
| 5 years | 1.01 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 2011-09-30 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 2026-02-25 |
| Compliance Officer | 39 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 75 | 2012-07-23 |
Steven Elms
CHM | Chairman | 62 | 2012-03-29 |
Alison Finger
BRD | Director/Board Member | 62 | 2023-09-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Tax | Compliance Officer | -3,177 | 0.0014% | ||
| 7/16/26 | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 5/27/26 | Buy | Founder | 6,400 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | -1.41% | -45.26% | +144.55% | 2.09B | |
| +0.43% | -3.94% | +37.72% | -3.70% | 79.3B | |
| -0.44% | +1.94% | -19.41% | -36.90% | 59.21B | |
| +3.07% | +2.36% | +487.70% | +25.73% | 55.09B | |
| +2.15% | -2.13% | -1.37% | +30.77% | 49.86B | |
| -0.55% | -2.14% | +8.08% | +160.02% | 47.9B | |
| +0.05% | +0.02% | +56.25% | -18.40% | 32.28B | |
| -0.81% | -3.96% | +42.95% | +90.47% | 25.21B | |
| -3.44% | +1.37% | +7.18% | +188.73% | 23.87B | |
| -3.52% | -0.27% | +59.29% | +113.04% | 16.89B | |
| Average | -0.21% | -1.45% | +63.31% | +69.43% | 39.17B | |
| Weighted average by Cap. | +0.23% | -1.90% | +84.26% | +42.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 535M 461M 433M 395M 744M 51.17B 746M 5.13B 2B 25.83B 2.01B 1.97B 85.64B | 700M 603M 566M 517M 973M 66.93B 976M 6.71B 2.62B 33.79B 2.63B 2.57B 112B |
| Net income | 191M 165M 155M 141M 266M 18.28B 267M 1.83B 715M 9.23B 718M 703M 30.6B | 248M 213M 200M 183M 344M 23.67B 345M 2.37B 926M 11.95B 930M 910M 39.61B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | US$9.420 | +0.86% | 239,995 |
| 26-08-28 | US$9.340 | -1.48% | 1,838,106 |
| 26-08-27 | US$9.480 | -1.56% | 1,496,384 |
| 26-08-26 | US$9.630 | -0.93% | 1,371,358 |
| 26-08-25 | US$9.720 | +1.78% | 1,479,039 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
